AAAAAA

   
Results: 1-9 |
Results: 9
PLATELET RESPONSE DURING PROSTAGLANDIN E-1-THERAPY IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS
Authors: KRITZ H OGUOGHO A FITSCHA P KALIMAN J ROGATTI W SINZINGER H
Citation: H. Kritz et al., PLATELET RESPONSE DURING PROSTAGLANDIN E-1-THERAPY IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Thrombosis research, 87(2), 1997, pp. 257-261
PROSTAGLANDIN E-1 DECREASES HUMAN ARTERIAL ACCUMULATION OF RADIOLABELED APO B-CONTAINING LIPOPROTEINS IN-VIVO
Authors: KRITZ H SINZINGER H LUPATTELLI G VIRGOLINI I FITSCHA P OGRADY J
Citation: H. Kritz et al., PROSTAGLANDIN E-1 DECREASES HUMAN ARTERIAL ACCUMULATION OF RADIOLABELED APO B-CONTAINING LIPOPROTEINS IN-VIVO, European Journal of Clinical Pharmacology, 52(3), 1997, pp. 191-197
PROSTAGLANDIN I-2-MEDIATED UP-REGULATION OF I-125 LDL-RECEPTOR BINDING BY ISRADIPINE IN NORMOCHOLESTEROLEMIC AND HYPERCHOLESTEROLEMIC RABBITS IN-VIVO
Authors: SINZINGER H LUPATTELLI G KRITZ H FITSCHA P OGRADY J
Citation: H. Sinzinger et al., PROSTAGLANDIN I-2-MEDIATED UP-REGULATION OF I-125 LDL-RECEPTOR BINDING BY ISRADIPINE IN NORMOCHOLESTEROLEMIC AND HYPERCHOLESTEROLEMIC RABBITS IN-VIVO, Prostaglandins, 52(2), 1996, pp. 77-91
PROSTAGLANDIN E(1) DECREASES CIRCULATING ENDOTHELIAL-CELLS
Authors: SINZINGER H FITSCHA P KRITZ H ROGATTI W OGRADY J
Citation: H. Sinzinger et al., PROSTAGLANDIN E(1) DECREASES CIRCULATING ENDOTHELIAL-CELLS, Prostaglandins, 51(1), 1996, pp. 61-68
PROSTAGLANDIN E(1)-THERAPY FOR PERIPHERAL VASCULAR-DISEASE INDUCES A LONG-LASTING BENEFIT ON MICROALBUMINURIA
Authors: SINZINGER H FITSCHA P KRITZ H SCHMID P PESKAR BA
Citation: H. Sinzinger et al., PROSTAGLANDIN E(1)-THERAPY FOR PERIPHERAL VASCULAR-DISEASE INDUCES A LONG-LASTING BENEFIT ON MICROALBUMINURIA, Circulation, 94(8), 1996, pp. 550-550
ISRADIPINE INHIBITS MITOTIC AND PROLIFERATIVE ACTIVITY IN THE ARTERIAL NAIL
Authors: FITSCHA P RAUSCHA F OGRADY J KEILER A SINZINGER H
Citation: P. Fitscha et al., ISRADIPINE INHIBITS MITOTIC AND PROLIFERATIVE ACTIVITY IN THE ARTERIAL NAIL, Experimental and toxicologic pathology, 46(1), 1994, pp. 75-80
A MULTICENTER STUDY USING CASUAL READINGS, SELF-RECORDINGS, AND AMBULATORY BLOOD-PRESSURE MONITORING TO ASSESS ISRADIPINE EFFECTS
Authors: MAGOMETSCHNIGG D FITSCHA P MEISNER W
Citation: D. Magometschnigg et al., A MULTICENTER STUDY USING CASUAL READINGS, SELF-RECORDINGS, AND AMBULATORY BLOOD-PRESSURE MONITORING TO ASSESS ISRADIPINE EFFECTS, American journal of hypertension, 7(7), 1994, pp. 190000040-190000045
ISRADIPINE DECREASES ARTERIAL THROMBOGENICITY IN RABBITS - A MORPHOMETRIC AND RADIOISOTOPIC STUDY
Authors: FITSCHA P KEILER A OGRADY J PESKAR BA SINZINGER H
Citation: P. Fitscha et al., ISRADIPINE DECREASES ARTERIAL THROMBOGENICITY IN RABBITS - A MORPHOMETRIC AND RADIOISOTOPIC STUDY, Thrombosis research, 74(3), 1994, pp. 175-183
EVIDENCE FOR INCREASED VASCULAR MONOCYTE ADHESION IN FAMILIAL HYPERCHOLESTEROLEMIA IN-VIVO - RISK FACTOR EVALUATION AND EFFECT OF TREATMENT
Authors: VIRGOLINI I LI SR YANG Q LUPATELLI G FITSCHA P GERRITY R SINZINGER H
Citation: I. Virgolini et al., EVIDENCE FOR INCREASED VASCULAR MONOCYTE ADHESION IN FAMILIAL HYPERCHOLESTEROLEMIA IN-VIVO - RISK FACTOR EVALUATION AND EFFECT OF TREATMENT, Thrombosis and haemostasis, 69(6), 1993, pp. 802-802
Risultati: 1-9 |